Resource > Articles >
Predicting Drug Bioavailability with the Modern-Day Toolkit
Filed under: ADME and Drug bioavailability
*This article is taken from International Biopharmaceutical Industry Winter 2021, pages 14-17.
WEBINAR: Normalization of organ-on-a-chip samples for mass spectrometry based proteomics and metabolomics via dansylation-based assay – 28 June 2023
